In conversation with Alexis Cockroft: driving sustainable, globally accessible cell and gene therapies through regulation

Meet the Cell & Gene Therapy Insights Editorial BoardIn celebration of Cell & Gene Therapy Insights’ 10th anniversary, Editorial Advisory Board member Dr Alexis Cockroft reflects on 20 years in regulatory affairs and lessons learned from supporting the approval of Strimvelis, Europe’s CGT innovation. They discuss the growing importance of decentralized manufacturing and global regulatory strategies, and why humility is essential to building safe, sustainable therapies with broad patient access.Alexis Cockroft, Director and Regulatory Consultant, Lex Regulatory Ltd